Related Experiment Videos
New glycosides from ajuga decumbens
1Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto 607-8414, Japan, and Faculty of Pharmacy, Meijo University, Yagotoyama, Tenpaku-ku, Nagoya 468-0077, Japan.
Journal of Natural Products
|September 28, 1998
Summary
Researchers discovered two new compounds, galactosylmartynoside and ajugaside A, from Ajuga decumbens. One compound, 8-acetylharpagide, showed significant inhibition of Epstein-Barr virus activation.
Area of Science:
- Natural Product Chemistry
- Pharmacology
- Phytochemistry
Background:
- The plant Ajuga decumbens is a source of bioactive compounds.
- Phenethyl alcohol glycosides and diterpene glycosides are classes of natural products with diverse biological activities.
Purpose of the Study:
- To isolate and characterize new chemical constituents from Ajuga decumbens.
- To evaluate the inhibitory effects of isolated compounds on Epstein-Barr virus activation.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation of new compounds via spectral data analysis (e.g., NMR, MS).
- Assay for Epstein-Barr virus activation inhibition using 12-O-tetradecanoylphorbol-13-acetate (TPA).
Main Results:
- Two new compounds, galactosylmartynoside (a phenethyl alcohol glycoside) and ajugaside A (an abietatriene-type diterpene glycoside), were identified.
- Several known compounds, including phenethyl alcohol glycosides and iridoid glycosides, were also isolated.
- 8-acetylharpagide demonstrated the most potent inhibition of TPA-induced Epstein-Barr virus activation among the tested compounds.
Conclusions:
- The study successfully identified novel glycosides from Ajuga decumbens.
- 8-acetylharpagide shows potential as an inhibitor of Epstein-Barr virus activation, warranting further investigation.